Kaan Certel - Nov 15, 2024 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGA)

Role
President and Chief Executive Officer, Director
Signature
/s/ Barbara Chan, Attorney-in-Fact for Kaan Certel
Stock symbol
OMGA
Transactions as of
Nov 15, 2024
Transactions value $
$0
Form type
4
Date filed
11/15/2024, 06:09 PM
Previous filing
May 31, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +340K $0.00 340K Nov 15, 2024 Common Stock 340K $0.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable with respect to 25% of the underlying shares on November 15, 2025 and in twelve (12) equal quarterly installments thereafter such that the option will become fully vested and exercisable on November 15, 2028, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

Remarks:

President and Chief Executive Officer